Posts

Novo Nordisk to Cut 400 Jobs at Bloomington, Indiana Facility Amid Prior Ownership Layoffs

on

FDA's PreCheck Pilot Program: Aligning on Regulatory Pathways to Avoid Approval Surprises

on

FDA Opens Submissions for PreCheck Pilot Program to Accelerate US Pharmaceutical Manufacturing Facilities

on

Novartis Announces Plans to Lay Off 550 Workers at Swiss Factory

on

Pharma Investment Surge in US Manufacturing Creates Major Opportunities for CDMOs

on

Eli Lilly Invests $6.5 Billion in Texas Facility to Manufacture Obesity Pill

on

Eli Lilly Picks Houston for $6.5 Billion API Manufacturing Facility

on

AbbVie Invests $195 Million in New North Chicago API Manufacturing Site

on

Sarepta Therapeutics Faces FDA Crackdown after Third Patient Death; George Tidmarsh Named Top FDA Drug Regulator; Multiple Drugs Rejected; Pharma Invests Billions in US Manufacturing

on

Thermo Fisher to Acquire Sanofi Factory; Amphastar Plans Major HQ Expansion

on

Sanofi Commits $20 Billion to US Expansion Amid Industry-Wide Investment Surge

on

'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge

on

Novo Nordisk Invests $1.1 Billion to Expand GLP-1 Drug Manufacturing in Brazil

on

Trump Announces Imminent Major Tariffs on Pharmaceuticals: Implications for Global Markets and U.S. Manufacturing

on

Lonza's Vision for the Future: A Fireside Chat with New CEO Wolfgang Wienand

on

Challenges in Moving Pharmaceutical Manufacturing to the US

on

The Perfect Storm: Why 2025 Will Be the Year of GxP AI in Pharma

on